The ability of Mycophenolate Mofetil to induce chromosome aberration and DNA damage in Mus Musculus Mice
Mycophenolate mofetil (MMF, cellcept) is widely used in maintenance immunosuppressive therapy for prevention refractory rejection in sold organ transplant recipients. MMF is orally used, and rapidly metabolized to its active constituent Mycophenolic acid. MPA is an inhibitor of Inosine Monophosphat...
Saved in:
| Main Authors: | RUIDA WATHEQ NEAMA, WAJDI SABEEH SADEQ |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Tikrit University
2019-12-01
|
| Series: | Tikrit Journal of Pure Science |
| Subjects: | |
| Online Access: | https://tjpsj.org/index.php/tjps/article/view/453 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycophenolate Mofetil and Clostridium difficile-associated Colitis
by: A. I. Dolgushina, et al.
Published: (2021-12-01) -
Mycophenolate Mofetil and Steroid for Treatment of Patients With IgA Nephropathy
by: Jing Miao, et al.
Published: (2024-01-01) -
Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice
by: Yuan Guo, et al.
Published: (2025-12-01) -
Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01) -
Indications and Long-Term Outcomes of Using Mycophenolate Mofetil Monotherapy in Substitution for Calcineurin Inhibitors in Liver Transplantation
by: Carlos Jiménez-Romero, et al.
Published: (2025-02-01)